MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Bistriatal hypermetabolism on 18-FDG PET-CT in tardive dyskinesia

    C. Héraud, C. Alecu, C. Giordana (NICE, France)

    Objective: Tardive dyskinesia (TD) describes various movement disorders developing after treatment with dopamine receptor blocking agents (DRBA), including stereotypy, akathisia, dystonia, tremor, tics and chorea.…
  • 2024 International Congress

    Response inhibition in patients with Lithium induced Tremor

    S. Banerjee, S. Choudhury, S. Majumdar, A. Bayen, P. Jakati, M. Baker, S. Baker, H. Kumar (KOLKATA, India)

    Objective: In the current study we explored the response inhibition paradigm through Stop Signal Reaction Time (SSRT) task in patients with lithium induced tremor. Background:…
  • 2024 International Congress

    Case Report: Carbamazepine-Induced Dystonia, Tremor and Negative Myoclonus

    D. Ouhabi, H. Naciri Darai, H. Tibar, W. Regragui (Rabat, Morocco)

    Objective: The objective of this case presentation is mainly to raise awareness of possible side effects of Carbamazepine in epileptic and non-epileptic patients, even years…
  • 2024 International Congress

    Complete Resolution of Tardive Dystonia After Bilateral Globus Pallidus Interna Deep Brain Stimulation

    L. Okar, P. Murin, C. Pratap (St.Louis, USA)

    Objective: To share an exciting case of a young lady with disabling generalized Tardive Dystonia (TD) with complete resolution of symptoms following bilateral Globus pallidus…
  • 2024 International Congress

    Misinterpretation of Hypnagogic/hypnopompic Experiences as Hallucinations in Parkinson’s Disease

    D. Urso, V. Gnoni, A. Giugno, M. Caccamo, A. Nanni, G. Logroscino, G. Foffani (Tricase, Italy)

    Objective: To investigate whether hypnagogic/hypnopompic experiences are clinically misinterpreted as hallucinations in Parkinson’s disease. Background: In Lewy body disorders, the progression of the disease can…
  • 2024 International Congress

    Diagnostic Challenges in Functional Neurological Disorder: Convergent Psychogenic Non-Epileptic Seizures and Psychosis

    D. Nolasco, R. Holbert, B. Carr (Gainesville, USA)

    Objective: To dissect the diagnostic challenges in distinguishing Functional Neurological Disorder (FND) coexisting with psychosis, highlighting the imperative for comprehensive and nuanced neuro-psychiatric assessment. Background:…
  • 2024 International Congress

    Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)

    Objective: To know the prevalence of Helicobacter Pylori infection among Nepalese Parkinson´s Disease patients and understand their clinical characteristics Background: Helicobacter pylori (HP) is prevalent…
  • 2024 International Congress

    Clinical correlates of apathy in Parkinson´s disease

    J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)

    Objective: To investigate the demographic and clinical correlates of apathy in a group of patients from a Movement Disorders clinic in Latin America. Background: Apathy…
  • 2024 International Congress

    Distress Tolerance in Patients with Tremor Disorders

    P. Sheehan, K. Pyle, M. Coleman, D. Sblendorio, D. Talkington, Y. Deng, A. Murray, A. Memon, N. Jasinski, M. Moreno-Escobar, J. Frey (Morgantown, USA)

    Objective: To examine the relationship of distress tolerance and symptom manifestation in patients with functional movement disorder(FMD), Parkinson’s disease(PD), and essential tremor(ET). Background: Patients with…
  • 2024 International Congress

    Parkinson’s disease biomarkers in human olfactory cleft mucus

    J. Morley, N. Cohen, S. Koganti, S. Wood, H. Wang (Philadelphia, USA)

    Objective: To investigate and identify biomarkers for PD from human olfactory cleft mucus Background: Olfactory loss is an early symptom of PD, often preceding motor…
  • « Previous Page
  • 1
  • …
  • 224
  • 225
  • 226
  • 227
  • 228
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley